Cryptococcal Immune Reconstitution Syndrome During Steroid Withdrawal Treated with Hydroxychloroquine
Overview
Affiliations
We present a case report of cryptococcal immune reconstitution syndrome (IRS), in a non HIV infected patient, which we treated with hydroxychloroquine with successful results. We briefly review cryptococcal IRS, possible mechanisms of action of hydroxychloroquine as an immunomodulatory agent, and its potential role in management of IRS.
Ito H, Yoshimoto T, Kokaze A, Wakabayashi K, Noguchi K, Matsui K BMC Infect Dis. 2025; 25(1):137.
PMID: 39875823 PMC: 11776137. DOI: 10.1186/s12879-025-10543-z.
Musubire A, Kagimu E, Mugabi T, Meya D, Boulware D, Bahr N Curr HIV/AIDS Rep. 2024; 21(2):75-85.
PMID: 38400871 PMC: 11016006. DOI: 10.1007/s11904-024-00691-3.
Wang X, Long X, Jia S, Zhu J, Zhou Z, Ahmed S Folia Microbiol (Praha). 2023; 68(4):595-605.
PMID: 36753031 DOI: 10.1007/s12223-023-01040-4.
Global HIV neurology: a comprehensive review.
Thakur K, Boubour A, Saylor D, Das M, Bearden D, Birbeck G AIDS. 2018; 33(2):163-184.
PMID: 29547440 PMC: 6139090. DOI: 10.1097/QAD.0000000000001796.
Huong N, Altibi A, Hoa N, Tuan L, Salman S, Morsy S BMC Infect Dis. 2017; 17(1):311.
PMID: 28446137 PMC: 5406963. DOI: 10.1186/s12879-017-2415-8.